GMO Pepabo, Inc. provided consolidated earnings guidance for the year ending December 31, 2023. For the year, the company expects net sales of JPY 10,894 million, operating loss of JPY 642 million, loss attributable to owners of parent JPY 867 million and basic loss per share of JPY 164.43.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,395 JPY | -0.64% | +0.22% | +19.33% |
02-13 | GMO Pepabo, Inc. Provides Dividend Guidance for the Year Ending December 31, 2024 | CI |
02-13 | GMO Pepabo, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.33% | 47.45M | |
+30.93% | 456B | |
+33.63% | 280B | |
+3.90% | 134B | |
+30.07% | 94.31B | |
+5.85% | 91.48B | |
+62.27% | 60.48B | |
+14.09% | 46.13B | |
+25.91% | 37.31B | |
-0.62% | 35.48B |
- Stock Market
- Equities
- 3633 Stock
- News GMO Pepabo, Inc.
- Gmo Pepabo, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2023